EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform— 510(k) K203131

Substantially Equivalent

Edwards Lifesciences, LLC

FDA 510(k) clearance K203131 for EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform, Substantially Equivalent on 2021-01-22. Applicant: Edwards Lifesciences, LLC. Device class: 2.

Clearance details

Applicant
Edwards Lifesciences, LLC
Product code
Code DXN
Device class
Class 2
Regulation
21 CFR 870.1130
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Irvine, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DXN

view all

More clearances from Edwards Lifesciences, LLC

view all

Adverse events under product code DXN

product code DXN
Death
3
Injury
169
Malfunction
1,019
Other
2
Total
1,193

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.